Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- AS1949490 (1)
- Angiogenesis (1)
- Antigen-presenting cells (1)
- Bethesda assay (1)
- Cancer Survivorship (1)
-
- Coagulation (1)
- Cytokines (1)
- Endothelial Cell Biology (1)
- Flow cytometry (1)
- Hemophilia (1)
- INPPL1 (1)
- Inflammation (1)
- Inhibitors (1)
- Lymphangiogenesis (1)
- Lymphatic System (1)
- Lymphedema (1)
- MAPK/ERK (1)
- Near Infrared Fluorescence Imaging (1)
- Next Generation Sequencing (1)
- PI3K/AKT (1)
- SHIP2 (1)
- TLR2 (1)
- TLR4 (1)
Articles 1 - 2 of 2
Full-Text Articles in Chemicals and Drugs
Src Homology 2 Domain-Containing 5’-Inositol Phosphatase-2 (Ship2) Is An Effector Of Lymphatic Dysfunction, Germaine D. Agollah
Src Homology 2 Domain-Containing 5’-Inositol Phosphatase-2 (Ship2) Is An Effector Of Lymphatic Dysfunction, Germaine D. Agollah
Dissertations & Theses (Open Access)
The lymphatic system is essential for the transport of excess fluid, protein, and foreign materials from interstitial tissues to lymph nodes; for immune surveillance, and to maintain fluid homeostasis. Dysregulated lymphatics can be attributed to pathological conditions including tumor metastasis, inflammation, chronic wounds, obesity, blood vascular disorders, and lymphedema. Of these, lymphedema is the most extreme of lymphatic disorders and is represented by a spectrum of symptoms ranging from mild, subtle presentation to severe, disfiguring, overt presentation. Lymphedema is more manageable in the early stages of disease but severely reduces quality of life with progression. Due to lack of molecular …
Stimulation Through Tlr4 Increases Fviii Inhibitor Formation In A Mouse Model Of Hemophilia A, Claire K. Holley
Stimulation Through Tlr4 Increases Fviii Inhibitor Formation In A Mouse Model Of Hemophilia A, Claire K. Holley
Dissertations & Theses (Open Access)
Hemophilia A is a clotting disorder caused by functional factor VIII (FVIII) deficiency. About 25% of patients treated with therapeutic recombinant FVIII develop antibodies (inhibitors) that render subsequent FVIII treatments ineffective. The immune mechanisms of inhibitor formation are not entirely understood, but circumstantial evidence indicates a role for increased inflammatory response, possibly via stimulation of Toll-like receptors (TLRs), at the time of FVIII immunization. I hypothesized that stimulation through TLR4 in conjunction with FVIII treatments would increase the formation of FVIII inhibitors. To test this hypothesis, FVIII K.O. mice were injected with recombinant human FVIII with or without concomitant doses …